Admission 24 hours prior, NPO for 8 hours, preoperative imaging review (MRI/CT), oncology consultation, prophylactic antibiotics, venous thromboembolism prophylaxis, and signed informed consent.
Post-operative monitoring in surgical ward, pain management, early mobilization with physical therapy, wound care, psychological support, and prosthetic rehabilitation coordination.
Comprehensive Clinical Guide: Transfemoral (Above-Knee) Amputation for Malignant Bone and Soft Tissue Tumors
1. Introduction and Clinical Overview
Transfemoral amputation (TFA), or above-knee amputation, represents a definitive surgical intervention in the management of high-grade malignant bone or soft tissue tumors located within the distal femur or proximal tibia. While modern orthopedic oncology has made significant strides in limb-salvage surgery (LSS), including endoprosthetic reconstruction and biological reconstruction, transfemoral amputation remains a critical, life-saving procedure when tumor characteristics preclude limb preservation.
In the context of oncology, the primary objective of a transfemoral amputation is the achievement of wide, tumor-free surgical margins (R0 resection). When tumor involvement compromises the neurovascular bundle, involves the proximal femur, or presents with extensive soft tissue contamination, amputation offers the most reliable oncological control, preventing local recurrence and allowing for systemic adjuvant therapies to proceed without the morbidity of a failed reconstructive attempt.
2. Technical Specifications and Surgical Mechanisms
The transfemoral amputation is a sophisticated reconstructive procedure, not merely a removal of tissue. The goal is to create a residual limb (stump) that is biomechanically optimized for prosthetic fitting, weight-bearing, and long-term durability.
Surgical Principles
- Myodesis/Myoplasty: The stabilization of divided muscles to the distal femur is paramount. Myodesis (anchoring muscles directly to bone through drill holes) is preferred to prevent muscle retraction and ensure active muscle control of the prosthetic limb.
- Neuroma Prevention: To mitigate the risk of symptomatic neuromas, peripheral nerves (sciatic, femoral, and saphenous branches) are identified, gently pulled distally, transected under tension, and allowed to retract into deep, well-vascularized soft tissue planes.
- Flap Design: Long posterior flaps are generally favored in oncological cases to ensure that the scar is placed anteriorly, away from the pressure-sensitive areas of the prosthetic socket.
Anatomical Levels of Amputation
| Level | Biomechanical Impact | Prosthetic Consideration |
|---|---|---|
| Distal Third | Preserves more lever arm for control. | Ideal for suspension and energy transfer. |
| Middle Third | Standard for most tumor resections. | Common, allows for hydraulic/microprocessor knees. |
| Proximal Third | Minimal lever arm; high energy expenditure. | Difficult to fit; requires specialized pelvic belts. |
3. Clinical Indications and Patient Selection
The decision to proceed with an above-knee amputation is usually multidisciplinary, involving orthopedic oncologists, vascular surgeons, oncologists, and physical medicine and rehabilitation (PM&R) specialists.
Primary Indications
- Tumor Location: Primary bone tumors (e.g., Osteosarcoma, Chondrosarcoma) involving the distal femur where neurovascular structures (popliteal artery/vein, sciatic nerve) are encased, making LSS impossible.
- Soft Tissue Sarcoma: High-grade sarcomas with deep compartment involvement where wide margins cannot be achieved without sacrificing the integrity of the limb.
- Failed Limb Salvage: Patients who have undergone previous LSS (e.g., endoprosthesis) who present with deep prosthetic infection or local recurrence.
- Pathological Fracture: Extensive bone destruction with poor bone stock that prevents secure fixation of a prosthesis.
- Palliative Care: In advanced, metastatic disease, amputation may be performed to manage intractable pain, fungating wounds, or severe functional impairment.
Contraindications
- Systemic Metastasis: While not an absolute contraindication, if the patient has a very limited life expectancy, the morbidity of a major amputation may outweigh the potential benefit.
- Poor Vascular Status: Pre-existing severe peripheral vascular disease may compromise wound healing at the amputation site.
4. Pre-Operative Preparation
Preparation involves both physical optimization and psychological support.
- Imaging: MRI is mandatory to determine the exact extent of tumor involvement and proximity to neurovascular bundles. CT of the chest is required to rule out pulmonary metastasis.
- Nutritional Assessment: Serum albumin and pre-albumin levels are checked; malnutrition is a leading cause of wound dehiscence in oncology patients.
- Psychological Counseling: The patient must be prepared for the body image changes associated with limb loss. Peer support groups are highly recommended.
- Prosthetic Consultation: A prosthetist should meet the patient pre-operatively to discuss future rehabilitation expectations, which significantly improves patient morale.
5. The Procedure: Step-by-Step
Stage 1: Incision and Dissection
Following regional or general anesthesia, the skin flaps are mapped to ensure they are well clear of the tumor margin. A posterior-based flap is commonly used.
Stage 2: Neurovascular Management
The femoral artery and vein are identified, ligated, and divided. The sciatic nerve is carefully dissected free, transected high to allow for retraction into the soft tissue, and protected from pressure.
Stage 3: Bone Transection
The femur is transected at the predetermined level. The end of the bone is smoothed (beveled) to remove sharp edges that could cause future skin breakdown.
Stage 4: Myoplasty/Myodesis
The quadriceps and hamstring muscles are sutured to the distal femur via drill holes. This ensures that the patient retains the ability to move the residual limb effectively.
Stage 5: Closure
The fascia and skin are closed in layers. Drains are typically placed to prevent hematoma formation, which is a major risk factor for infection.
6. Post-Operative Recovery and Rehabilitation
Immediate Phase (0–2 weeks)
- Wound Care: Strict monitoring of the incision for signs of infection or necrosis.
- Edema Control: Use of a rigid dressing or compressive elastic bandages to shape the residual limb and reduce swelling.
- Pain Management: Multimodal analgesia, including peripheral nerve blocks, to prevent the development of chronic phantom limb pain.
Intermediate Phase (2–8 weeks)
- Physical Therapy: Focus on strengthening the core and the hip extensors/abductors.
- Desensitization: The patient is taught to massage the residual limb to reduce hypersensitivity.
Long-Term Phase (3+ months)
- Prosthetic Fitting: Once the residual limb is well-healed and edema has subsided, the patient is fitted for a definitive prosthesis.
- Gait Training: Learning to ambulate with a microprocessor-controlled knee or mechanical knee unit.
7. Potential Complications
| Complication | Mechanism | Mitigation Strategy |
|---|---|---|
| Phantom Limb Pain | Central nervous system reorganization. | Gabapentinoids, mirror therapy, nerve sheath management. |
| Wound Dehiscence | Poor vascularity or tension on closure. | Meticulous surgical technique; nutritional optimization. |
| Symptomatic Neuroma | Improper nerve handling. | High transection and deep soft-tissue coverage. |
| Infection | Post-operative contamination. | Prophylactic antibiotics; strict aseptic technique. |
| Heterotopic Ossification | Bone growth in soft tissue. | Proper bone beveling and post-op anti-inflammatories. |
8. Alternative Treatments
While amputation is often a "last resort," the following alternatives are considered when the tumor allows:
* Limb-Salvage Surgery (LSS): Use of modular endoprostheses to replace the distal femur.
* Rotationplasty: A specialized procedure where the ankle joint is rotated 180 degrees and attached to the femur, allowing the ankle to function as a knee joint.
* Allograft Reconstruction: Biological reconstruction using donor bone.
* Chemotherapy/Radiation: Sometimes used as neoadjuvant treatment to shrink the tumor, potentially allowing for a less radical surgical approach.
9. Frequently Asked Questions (FAQ)
1. Will I be able to walk again after an above-knee amputation?
Yes, the vast majority of patients successfully return to ambulation using a modern prosthetic limb, especially with today's advanced microprocessor-controlled knees.
2. What is "phantom limb pain"?
It is the sensation of pain or discomfort in the part of the limb that is no longer there. It is common and is treated with a combination of medication, physical therapy, and psychological support.
3. How long does the surgery take?
A transfemoral amputation typically takes between 2 to 4 hours, depending on the complexity of the soft tissue dissection.
4. How long until I am fitted for a prosthesis?
Usually, patients are fitted for a preparatory prosthesis 6 to 8 weeks post-surgery, once the wound is completely healed and the limb shape has stabilized.
5. Why is the bone beveled during surgery?
Beveling the bone edges prevents the bone from pressing against the skin and muscles, reducing the risk of pain and skin breakdown inside the prosthetic socket.
6. Can I still play sports?
Many patients return to active lifestyles. Specialized prosthetic components are available for running, swimming, and cycling.
7. What is the risk of the tumor returning?
The risk depends on the histological grade of the tumor and whether the surgical margins were clear. Amputation provides the best chance for local control.
8. Will the surgery affect my hip movement?
By performing a proper myodesis, we ensure that the muscles controlling the hip remain attached to the bone, preserving full range of motion at the hip joint.
9. How do I prevent infection after surgery?
Keep the incision clean and dry, follow all wound care instructions, and monitor for redness, swelling, or drainage.
10. Is an above-knee amputation always necessary for bone tumors?
No. It is only recommended when limb-salvage surgery is deemed unsafe or oncologically inappropriate due to the extent of the tumor.
10. Conclusion
A transfemoral amputation for a tumor is a life-altering event, but in the hands of a skilled orthopedic oncology team, it is a procedure that provides a foundation for the patient to return to a high quality of life. By focusing on oncological safety, precise surgical technique, and comprehensive rehabilitation, patients can navigate the recovery process successfully and return to their daily activities with confidence. Always consult with your primary oncology surgeon to discuss the specific risks and benefits tailored to your clinical presentation.